跳转至内容
Merck

BP464

泼尼松龙

British Pharmacopoeia (BP) Assay Standard

别名:

1,4-孕甾二烯-11β,17α,21-三醇-3,20-二酮, 1-去氢氢化可的松, 1-去氢皮质醇, 11β,17α,21-三羟基-1,4-孕甾二烯-3,20-二酮

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C21H28O5
CAS号:
分子量:
360.44
Beilstein:
1354103
EC號碼:
MDL號碼:
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

prednisolone

形狀

crystalline

儲存期限

limited shelf life, expiry date on the label

製造商/商標名

BP

mp

240 °C (dec.) (lit.)

應用

pharmaceutical
pharmaceutical small molecule

格式

neat

SMILES 字串

O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@]2([H])[C@@H](O)C[C@@]4(C)[C@@]3([H])CC[C@]4(O)C(CO)=O)=C1

InChI

1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1

InChI 密鑰

OIGNJSKKLXVSLS-VWUMJDOOSA-N

基因資訊

human ... NR3C1(2908)

正在寻找类似产品? 访问 产品对比指南

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Prednisolone BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Estriol Cream
  • Prednisolone Sodium Phosphate Ear Drops
  • Prednisolone Sodium Phosphate Eye Drops
  • Prednisolone Tablets
  • Prednisolone Soluble Tablets
  • Prednisolone Enema
  • Prednisolone Sodium Phosphate Oral Solution
  • Prednisolone Gastro-resistant Tablets
  • 其他說明

    Sales restrictions may apply.

    相關產品

    产品编号
    说明
    价格

    象形圖

    Health hazard

    訊號詞

    Danger

    危險聲明

    危險分類

    Repr. 1B

    儲存類別代碼

    6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

    水污染物質分類(WGK)

    WGK 2


    Choose from one of the most recent versions:

    分析证书(COA)

    Lot/Batch Number

    Sorry, we don't have COAs for this product available online at this time.

    If you need assistance, please contact 客户支持

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Eng Cern Gan et al.
    International forum of allergy & rhinology, 4(11), 877-884 (2014-08-20)
    The endoscopically magnified operative field in functional endoscopic sinus surgery (FESS) makes even a small amount of bleeding a potentially significant hindrance. It is thought that irrigation with hot saline during surgery may improve surgical field of view by producing
    Ramachandran Venkitaraman et al.
    European urology, 67(4), 673-679 (2014-12-03)
    Prednisolone is widely used as secondary hormonal treatment for castration-resistant prostate cancer (CRPC). We hypothesised that dexamethasone, another corticosteroid, is more active. To compare the activity of prednisolone and dexamethasone in CRPC. This single-centre, randomised, phase 2 trial was performed
    C Motteram et al.
    Reproductive biomedicine online, 30(4), 340-348 (2015-02-14)
    The effectiveness of combined co-treatment with aspirin, doxycycline, prednisolone, with or without oestradiol patches, was investigated on live birth (LBR) rates after fresh and frozen embryo transfers (FET) in IVF and intracytoplasmic sperm injection cycles. Cases (n = 485) and
    T Bakchoul et al.
    Journal of thrombosis and haemostasis : JTH, 12(6), 871-878 (2014-03-25)
    Heparin, the standard perioperative anticoagulant for the prevention of graft vessel thrombosis in patients undergoing liver transplantation (LT), binds to the chemokine platelet factor 4 (PF4). Antibodies that are formed against the resulting PF4/heparin complexes can induce heparin-induced thrombocytopenia. LT
    M Tyblova et al.
    European journal of neurology, 22(4), 624-632 (2014-06-17)
    The prevalence of osteopenia and osteoporosis is higher amongst patients with multiple sclerosis in comparison with the general population. In addition to the general determinants of bone health, two factors may contribute to reduced bone mineral density in multiple sclerosis:

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系技术服务部门